Literature DB >> 24372473

Commonly asked questions in the treatment of obsessive-compulsive disorder.

Shyam Sundar Arumugham1, Y C Janardhan Reddy.   

Abstract

Obsessive-compulsive disorder (OCD) is a common and often a highly disabling condition that was considered untreatable before the 1960s. The advent of serotonin reuptake inhibitors and exposure and response prevention revolutionized the treatment of OCD. Although they are still the first line treatments for OCD, new treatments like augmentation strategies, brain stimulation techniques, psychosurgery, newer forms of psychotherapy (like cognitive therapy, acceptance and commitment therapy) have been added to the armamentarium. With the available treatment strategies, many patients can achieve at least partial remission of symptoms. Nevertheless, the plethora of information gives rise to many questions on their application for practicing clinicians. We provide evidence-based responses to these questions and suggest a broad guideline for treatment of OCD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24372473     DOI: 10.1586/14737175.2014.874287

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  3 in total

1.  Successful Treatment Response with Aripiprazole Augmentation of SSRIs in Refractory Obsessive-Compulsive Disorder in Childhood.

Authors:  Ulku Akyol Ardic; Eyup Sabri Ercan; Ayse Kutlu; Deniz Yuce; Melis Ipci; Sevim Berrin Inci
Journal:  Child Psychiatry Hum Dev       Date:  2017-10

2.  Clinical practice guidelines for Obsessive-Compulsive Disorder.

Authors:  Y C Janardhan Reddy; A Shyam Sundar; Janardhanan C Narayanaswamy; Suresh Bada Math
Journal:  Indian J Psychiatry       Date:  2017-01       Impact factor: 1.759

3.  Identification of biomarkers that predict response to subthalamic nucleus deep brain stimulation in resistant obsessive-compulsive disorder: protocol for an open-label follow-up study.

Authors:  Shyam Sundar Arumugham; Dwarakanath Srinivas; Janardhanan C Narayanaswamy; T S Jaisoorya; Himani Kashyap; Philippe Domenech; Stéphane Palfi; Luc Mallet; Ganesan Venkatasubramanian; Yc Janardhan Reddy
Journal:  BMJ Open       Date:  2021-06-22       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.